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TransmissibilityInﬂuenza A virus strains adopt different host speciﬁcitiesmainly depending on their hemagglutinin (HA) protein.
Via HA, the virus binds sialic acid receptors of the host cell and, upon endocytic uptake, HA triggers fusion be-
tween the viral envelope bilayer and the endosomal membrane by a low pH-induced conformational change
leading to the release of the viral genome into the host cell cytoplasm. Both functions are crucial for viral infection
enabling the genesis of new progeny virus.
Adaptation to different hosts in vitro was shown to require mutations within HA altering the receptor binding
and/or fusion behavior of the respective virus strain. Human adapted inﬂuenza virus strains (H1N1, H3N2,
H2N2) aswell as recent avian inﬂuenza virus strains (H5, H7 and H9 subtypes) which gained the ability to infect
humansmostly containedmutations in the receptor binding site (RBS) of HA enabling increased binding afﬁnity
of these viruses to human type (α-2,6 linked sialic acid) receptors. Thus, the receptor binding speciﬁcity seems to
be the major requirement for successful adaptation to the human host; however, the RBS is not the only deter-
minant of host speciﬁcity. Increased binding to a certain cell type does not always correlate with infection efﬁ-
ciency. Furthermore, viruses carrying mutations in the RBS often resulted in reduced viral ﬁtness and were still
unable to transmit betweenmammals. Recently, the pH stability of HAwas reported to affect the transmissibility
of inﬂuenza viruses. This review summarizes recent ﬁndings on the adaptation of inﬂuenza A viruses to the
human host and related amino acid substitutions resulting in altered receptor binding speciﬁcity and/or modu-
lated fusion pH of HA. Furthermore, the role of these properties (receptor speciﬁcity and pH stability of HA) for
adaptation to and transmissibility in the human host is discussed. This article is part of a Special Issue entitled:
Viral Membrane Protiens – Channels for Cellular Networking.
© 2013 Elsevier B.V. All rights reserved.Contents
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Inﬂuenza A viruses have been a known burden for mankind since
the beginning of the 20th century. Infection of a variety of hosts such
as birds, horses, dogs and swine causes high morbidity and mortality
among these species associated with huge economic losses. Further-
more, seasonal (epidemic) outbreaks of the human ﬂu also have serious
consequences, especially for the elderly population. The high variability
of different virus strains, their constant evolution in birds and the
resulting reassortment of novel, sometimes highly pathogenic inﬂuenza
viruses in respective hosts (swine) complicates the development of
new vaccines which can effectively inhibit or prevent infection with in-
ﬂuenza viruses.
The negative stranded RNA virus belongs to the family of
Orthomyxoviridae. It has a segmented genome encapsulated by the M1
matrix protein. This capsid is surrounded by the host cell-derived lipid
membrane. Embedded in the envelope membrane are the proton chan-
nel proteinM2, essential for proton transport across the viralmembrane,
and the two glycoproteins hemagglutinin (HA) and neuraminidase (NA)
which are important for entry [1] and budding of new viruses from the
cell surface [2], respectively. Since they are exposed at the surface of
the virus, HA and NA also serve as antigens and thus as major targets
for vaccine design. The segmented genome is composed of single-
stranded negative sense RNA decorated with the nucleoprotein NP and
the trimeric polymerase complex consisting of the proteins PB1, PB2
and PA (Fig. 1).
Based on the antigenic properties of HA and NA, inﬂuenza A viruses
can be classiﬁed into 17 subtypes of HA (H1 to H17) and ten of NA
(N1 to N10). Furthermore, the segmented genome allows the virus to
reassort with different strains upon co-infection of a host so that
novel viruses emerge constantly with a new composition of segments
and subtypes (antigenic shift) [3]. All of these subtypes circulate in
aquatic wild birds, their natural reservoir, mostly without causing any
symptoms. Only when transmitted to poultry, lower mammals and
humans, they cause respiratory disease. To date only viruses with HA
of subtype H1, H2 and H3 and NA of subtype N1 and N2 are known to
have successfully adapted to humans among which they keep circulat-
ing causing the annual human ﬂu [4]. The avianH5 andH7 subtypes can
be further classiﬁed in low and highly pathogenic viruses according to
their mortality rates in infected chickens. Different to low pathogenic
avian inﬂuenza viruses (LPAIV) which cause milder respiratory disease,
highly pathogenic avian inﬂuenza viruses (HPAIV) provoke severe dis-
ease resulting in up to 100% mortality among poultry within 48 h
[5,6]. In 2004, a very aggressive form of H5N1 HPAIV caused millions
of deaths among birds associated with a growing number of spill-over
infections from birds to humans or other mammals. Efﬁcient human-
to-human transmission has fortunately not been reported due to
limited binding to human-type receptors, which is thought to be the
major factor in determining the interspecies barrier [7–9]. Still, there
is a great risk for the development of a human pathogenic H5N1 strain.
In 2001, it was reported that only four mutations in the HA protein
would be sufﬁcient to turn the avian pathogenic H5N1 into a human
pathogenic strain [6]. Additionally, an increasing number of human in-
fections with avian H7N9 have been reported. From March until May2013 approximately 130 cases have been detectedwith a highmortality
of 21% [10,11]. Thus, precise surveillance of circulating inﬂuenza viruses
and a better understanding of human-adaptive mutations would im-
prove the forecast of a potential outbreak of a human pathogenic strain
and help to prevent human pandemics.
For successful adaptation to a different host,mutations in several viral
genes are required. For example, mutation E627K in the PB2 gene, which
is one of the viral polymerase proteins, is known to confer higher replica-
tion efﬁciency at 37°C [12–14]. Also substitutions in other viral proteins
have been detected improving replication efﬁciency in the respective
host [15–17]. These originate from the missing proof reading activity of
the viral polymerase resulting in a high error rate during replication
and endowing the virus with great ﬂexibility (antigenic drift) [3].
Mutations of the inﬂuenza virus HA seem to have themost dramatic
effect on virus pathogenicity. As interaction partner, fusion initiator and
antigen, HA has several important functions in the ﬁrst, crucial steps of
virus infection. It mediates binding of the virus to sialic acid (SA) cell re-
ceptors and, after endocytosis of the virus particle, controls the release
of the viral genome into the cell by a pH-dependent membrane fusion
process (Fig. 2). Only efﬁcient membrane fusion, i.e. formation of a fu-
sion pore and release and transport of the viral RNPs into the nucleus,
leads to the replication of new viral RNA, transcription and translation
of the viral proteins and subsequent formation of new progeny virus
[18,19].
Several studies have shown that mutations within HA can be sufﬁ-
cient for adaptation of an avian HA to a mammalian host [16,20–22].
Inmost cases thesewere linked to altered receptor binding or fusion ac-
tivity. However, the variety of different strains andHA subtypes coupled
with difﬁculty in assessing contributing host factors complicates the
conﬁdent prediction of a new human pathogenic reassortant based on
these studies. The high variability among inﬂuenza virus strains and
their HAs correlates with a remarkable divergence among hosts, tissues
and cells showing different susceptibilities to virus infection. Here, we
review the role of HA-mediated cell binding and membrane fusion in
inﬂuenza A virus infection considering these cell-speciﬁc differences.
Furthermore, we describe how amino acid changes in different HA sub-
types affect receptor binding and fusion behavior of the virus and how
these changes contribute to host speciﬁc virus infection and successful
interspecies transmission.2. Structure and function of the hemagglutinin protein
Theﬁrst crystal structure of HA from inﬂuenza A/HongKong/1968 at
neutral pH was obtained by bromelain cleavage yielding the water sol-
uble ectodomain of the glycoprotein (BHA) [23]. It is comprised of a
triple-stranded coiled-coil of α-helices (stalk region comprising resi-
dues of HA1 andHA2) and a globular region of antiparallel β-sheets (re-
ceptor binding domain R, HA1) (Fig. 3). The receptor binding site (RBS)
and the highly variable antigenic binding loops surrounding the RBS are
located on the top of the R domain [1]. They usually carry carbohydrate
side chains which are as well crucial for virus infection, especially for
evading the host immune response [23–26]. Apart from the receptor
binding domain R, theHA1 subunit also consists of the vestigial esterase
Fig. 1. (A) Schematic representation of an inﬂuenza A virus particle. The spike proteins hemagglutinin (HA, blue), neuraminidase (NA, green) and the proton channel protein M2 (violet) are
embedded in the lipid envelope (turquoise) of the virus. Themembrane is linedwith theM1 capsid protein at the inside (yellow). The viral genome consists of eight ribonucleoprotein particles
(RNPs, red),with each segment formedby viral RNA (vRNA), the nucleoprotein (NP) and the viral polymerase proteins (PB1, PB2 and PA, colored in gray). (B) Transmission electronmicrograph
of an inﬂuenza A/X-31 virion. Regions of the lipid membrane (turquoise) and of the M1 capsid (yellow) as well as one RNP (red) are colorized. In the magniﬁed section of the electron micro-
graphHA andNAwere overlaidwith surface representations of the corresponding crystal structures ﬁltered to an EM-comparable resolution (attainable by 3D-TEM-reconstruction techniques)
[58]. On the right side the enlarged surface representation of the HA 3D-structure is overlaid with its secondary structure (PDB ID: 2YPG, monomers in green, red, yellow).
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with the HA2 subunit of the protein [27].
The coiled-coil structure of HA2 (stalk domain) is crucial for the sta-
bilization of the HA trimer and for anchoring the protein in the mem-
brane via its transmembrane (TM) subdomain. This stabilizing central
α-helical rod-like oligomer is also observed in other viral fusion pro-
teins such as the Ebola glycoprotein Gp2 [28] or the HIV-1 gp-41 [29].
Furthermore, the HA2 subunit carries the fusion peptide (20–25 resi-
dues) at its N-terminus, which is essential for the membrane fusion ac-
tivity of the protein [30]. Other important structural elements of the
HA2 domain include the B loop connecting the long α-helix (helix A)
of the stalk domain with the shorter helix at the outside (helix C) and
a short part of the helix A itself (residues 106–112 of HA2). These ele-
ments could be determined by comparison of the pre-fusion (BHA)
and the post-fusion structure of HA (TBHA2) [31]. The latter was re-
solved by low pH incubation of BHAwith subsequent digestion by tryp-
sin and thermolysin before crystallization [31,32]. It was found that the
TBHA2 seems to be the energetically favored state of the protein [33,34].
The receptor binding domain appears to be structurally consistent be-
tween the pre-fusion structure [35] and its low-pH dissociated state
[36].
2.1. Expression and cleavage
In infected cells, the hemagglutinin glycoprotein is produced as
the precursor HA0. With the help of chaperones, HA0 monomersassemble into non-covalently linked homotrimers that subsequently
travel through the Golgi apparatus to the plasma membrane [37,38].
Each HA0 monomer has to be cleaved by host proteases into the sub-
units HA1 andHA2 to be functional, i.e. able to inducemembrane fusion
[23,30,39–41]. Furthermore, cleavage liberates the N-terminal fusion
peptide of HA2. Due to the positively charged N-terminal amino group
the fusion peptide becomes buried in a negatively charged cavity of
HA, the so called fusion peptide pocket [23,42,43]. Cleavage happens
either during the course of intracellular transport or extracellularly at
the plasma membrane depending on the sequence of the cleavage site.
For most HAs, the cleavage site between HA1 and HA2 is a single ar-
ginine residue (monobasic cleavage site) and the precursor is cleaved by
extracellular enzymes. However, in some avian HAs (H5 and H7), the
cleavage site is longer and contains multiple basic residues (arginines
or lysines, polybasic cleavage site) [44–46]. The presence of a polybasic
cleavage site directly correlates with enhanced pathogenicity as it is
cleaved by a family of widespread subtilisin-like proteases such as
furin and PC6, which act on HA intracellularly after exit from the ER.
These subtilisin-like proteases are ubiquitously expressed resulting in a
more efﬁcient cleavage and systemic spread of the virus over the course
of the infection. In contrast, the monobasic cleavage site of HA of low
pathogenic viruses can only be cleaved extracellularly by serine prote-
ases. These trypsin-like enzymes are only secreted in the avian and
human lung epithelium (e.g. tryptase Clara, TMPRSS2 and HAT [43,47])
and in the intestinal tract of birds, e.g. factor Xa-like proteases. The re-
stricted range of cells secreting such a protease results in anatomically
Fig. 2. Replication cycle of an inﬂuenza A virus. After the virus has bound to sialic acid-
containing receptors via hemagglutinin (1) it gets endocytosed (2) and is transported
within the endosome alongmicrotubules (3). The declining endosomal pH triggers a con-
formational change ofHAmediating the fusion of the viral and endosomalmembrane. As a
consequence, the RNPs are released into the cytoplasm and are ﬁnally transported into the
nucleus (4). There the viral RNA is transcribed into mRNA and new viral RNA (via cRNA
intermediate) (5). From the newly synthesized mRNA viral membrane proteins (HA, NA
andM2) are produced at the endoplasmic reticulum (ER) and travel through theGolgi ap-
paratus to the plasma membrane of the cell (6). Other early (PB1, PB2, PA, NP and NS1)
and late (M1 and NS2) viral proteins are also translated and transported back into the nu-
cleus where new ribonucleoprotein particles (vRNPs) are formed with the nucleoprotein
(NP) and the trimeric polymerase complex (PB1, PB2, PA) (7). These new vRNPs, aswell as
M1, are also transported to the plasma membrane, where assembly of new viral particles
takes place which subsequently bud from the plasma membrane (8).
Fig. 3. Crystal structure of HA from Inﬂuenza A/X-31 virus (H3N2) (PDB ID: 2YPG). Onemonom
binding domain, R), yellow (vestigial esterase domain, E′) and blue (fusion domain, F′) and the
bohydrate moieties in black. The magniﬁcation in the R subdomain of HA1 shows the structura
220-loop in pink) in complex with a human-type receptor analog (dark gray). Conserved resid
transparent).
1156 C.M. Mair et al. / Biochimica et Biophysica Acta 1838 (2014) 1153–1168localized and hence milder infections [48]. Therefore, efﬁciency of pro-
teolytic cleavage does not only depend on the virus strain (LPAIV or
HPAIV) but also on the host cell proteolytic enzyme machinery. Secre-
tion of serine proteases activating theHA of LPAIV is limited to a number
of tissues and cells leading to reduced viral replication. However, other
viral or bacterial lung infections can contribute to the secretion of en-
zymes such as thrombin and plasmin capable of HA cleavage [41]. The
presence of host proteases inﬂuencing cleavage activation of HA is only
one of several host speciﬁc factors affecting the infection potential of
an inﬂuenza virus which are described later in this review.
2.2. Receptor binding
The receptor on the host cell surface is N-acetyl-neuraminic acid,
generally called sialic acid (SA), which inserts into the receptor binding
pocket at the top of the HA1 subunit. The RBS is formed by three do-
mains, the 130-loop (residues 134–138), the 190-helix (residues 188–
195) and the 220-loop (residues 221–228) (Fig. 3). However, only
some of the residues directly interact with the receptor sialic acid. For
example, in the H3 subtype Y98, W153, E190, Y195 and H183 were
identiﬁed to interact through hydrogen bonds with the side chains of
SA [49,50]. Three of these residues (Y98, W153 and H183) are highly
conserved throughout all HA subtypes except from the recently identi-
ﬁed H17 subtype of bat derived H17N10 [51]. Other residues of the RBS
interact with the adjacent sugars of sialic acid and play an important
role for the receptor speciﬁcity of HA as described in Section 3.1.
In general, the mechanism of viral sugar binding greatly differs from
the binding mechanism of human sugar binding proteins, such as
galectins. The latter have an open structurewhich is muchmore accessi-
ble compared to the hidden cavity of HA and other viral lectins [52]. De-
spite this discrepancy, the RBS of HA is thought to be derived from the
same host galectin as human galectins. Interestingly, H17 has a ratherer is shown in cartoon representation with subdomains of HA1 labeled in green (receptor
HA2 subunit in red. The other monomers are displayed in surface representation with car-
l elements of HA1 forming the receptor binding site (130-loop in blue, 190-helix in green,
ues forming hydrogen bonds with sialic acid are displayed in stick representation (yellow
Fig. 4. Conformational change of the inﬂuenza virus HA at acidic pH (5.0–6.0). In the upper part of the image the steps of conformational change are illustrated (HA1 in gold, HA2 in gray
and black, fusion peptide in red). Upon acidiﬁcation in the endosome protonation of HA1 leads to the dissociation of the HA1 monomers (1). Water can enter triggering the structural
transition of the B-loop into a helix and liberating the fusion peptide which inserts into the endosomal membrane yielding the extended intermediate conformation of HA (2). Refolding
of amino acid residues (aa) 106–112 of the helix A into a loop ﬁnally mediates the apposition of the twomembranes triggering fusion (hairpin conformation of HA) (3). The lower part of
the image shows the corresponding secondary structures of trimeric HA of A/X-31 (H3N2) at neutral (PDB ID: 2YPG) and low pH (hairpin structure, PDB ID: 1HTM) in surface (HA1,
yellow-orange) and cartoon representation (HA2, gray) with structural elements undergoing a conformational change highlighted in black. TM is the transmembrane region of HA.
1157C.M. Mair et al. / Biochimica et Biophysica Acta 1838 (2014) 1153–1168ﬂat RBS comparable to human sugar binding motifs in contrast to the
shallow pocket in all other viral HA proteins. For this HA subtype, bind-
ing to sialic acid-containing receptors has not been observed and hence
itwas speculated that this subtypemight have analternativemechanism
of cell attachment [51,52].
2.3. Fusion activity
The merger of twomembranes is a thermodynamically favored pro-
cess but has a high kinetic barrier. The energy to overcome this barrier is
thought to be provided by the “spring-loaded” mechanism of HA
conformational change, also observed for other viral fusion proteins
[53,54]. As mentioned above, the fusion peptide of HA2 plays an impor-
tant role in the membrane fusion process. Upon acidiﬁcation in the
endosome (pH5.0–6.0) and the conformational change of HA, it gets ex-
posed and inserts into the target membrane inducing themerger of the
two membranes [1,42,55–57]. However, the process of conformational
change and membrane fusion is not as simple and involves structural
rearrangements in both, the HA1 and HA2 domains.
A sequence of threemajor stepswas discussed for the conformation-
al change of HA: (1) Protonation of HA1 leads to the dissociation of
intra-trimeric and inter-subunit contacts allowing water to enter the
ectodomain having now access to sequences which have originally
been shielded from contact with water [55,58]. (2) Interaction with
water triggers the B loop of the HA2 N-terminus to undergo a loop-to-
helix transition resulting in the extended coiled-coil conformation of
the threemonomers (extended intermediate) [59]. (3) Due to refolding
of helix A into a loop, the extended intermediate collapses and thereby
draws the fusion peptide towards the transmembrane region (hairpin
conformation) leading to lipid mixing and the formation of a fusion
pore [53,59] (Fig. 4). Cryo-EM studies and characterization of HA mu-
tants locking the protein in (mostly) reversible intermediates strongly
support this model [58,60,61]. Partial opening of the HA1 monomers(1) was observed by cryo-EM for the trimeric ectodomain (BHA) [58]
as well as for HA in intact virus particles [62] upon incubation at low
pH. Furthermore, incomplete formation of the extended coiled-coil
conformation (2) due to mutations in the B-loop (F63P, F70P) was
shown to inhibit membrane fusion emphasizing the importance of a
fully extended intermediate state for the formation of a fusion pore
[63]. All of these studies report (partly reversible) intermediate states
of the HA that are essential for complete membrane fusion and precede
the ﬁnal irreversible hairpin structure of HA2 [58,62,64].
Lee et al. [65] suggested a differentmodel ofmembrane fusion based
on observations of virus–liposome complexes at pH5.5 by cryo-electron
tomography (CET). In contrast to the conventional model of membrane
fusion, dissociation of HA1-monomers (1) and insertion of the fusion
peptide into the target membrane (2) are proposed to be followed by
membrane scission (3) (breakage of the target membrane) while the
viral membrane stays intact. The author further proposes that, after
the apposition of the two membranes (due to refolding of HA2 into
the hairpin structure) leading to lipid mixing (4), dissolution of thema-
trix layer M1 at pHb5.0 is required for fusion pore formation (5). Thus,
M1was suggested to play an essential role inmembrane fusion control-
ling the release of the viral RNPs at a lower pH than that of HA confor-
mational change.
3. Role of HA for host-speciﬁc virus infection and adaptation
The signiﬁcance of the hemagglutinin glycoprotein for viral infection
and host adaptation has been reported several times [1,30,39,66,67]. In
the ﬁrst steps, from viral attachment throughmembrane fusion, the HA
protein plays an important role for antigenicity, host susceptibility and
pathogenicity of the virus. Binding and uptake by a certain host cell is
mostly determined by the composition of the RBS of the HA1 domain
(receptor binding speciﬁcity) whereas the fusion potential of HA is
correlated to its pH-dependent stability. Hence, for a given virus the
Table 1
Residues affecting the receptor binding speciﬁcity of different HA subtypes. Residues highlighted were shown to confer transmissibility in the mammalian host.
Avian HA Mutation (H3 numbering) position receptor speciﬁcity Delta fusion pH RD transmission [units] Literature
α–2,3 SA α–2,6 SA
H1 E190D, G225D R, RBS – ++ n.a. Yes [79,80,163,164]
H2, H3 Q226 L, G228S R, RBS – ++ n.a. Yes [68,79,165]
G218E/W R, HA1–HA1 + + +0.4 No [108,124,125]
T2156N F, HA1–HA2 ++ – +0.1 – [124]
S223N R, RBS + + n.a. – [49,166]
S227P RBS – + n.a. – [79]
H5 L133V, A138V R, RBS + + n.a. – [89,126,167]
N186K (+M230I) R, RBS + + n.a. – [21,90,126]
Q196R (+ N186K) R, RBS + + n.a. – [90]
Q226 L, G228S R, RBS + + n.a. No [20,21,86,89,120]
+E190D R, RBS + + n.a. No [86,87]
+K193R R, far from RBS + + n.a. No [86,89]
+D187G, E190D, K193S R, RBS + + n.a. No [86,91]
+Q196R R, RBS – ++ n.a. Yes [91]
+T160A R, close to RBS – ++ + No [20,88,89]
+T160A, H110Y E', HA1–HA2 – ++ – Yes [20,101]
N224K, Q226 L R, RBS – + +0.3 No [21]
+N158D/A R, RBS – ++ +0.3 No [21]
+N158D, T318I F', HA1–HA2 – ++ -0.3 Yes [21]
V152I, Q226 L R, close to RBS + + n.a. No [21]
S227N, G228A R, RBS + + n.a. No [21,77,120]
S227N, Q196R R, RBS + + n.a. No [90,91]
Q226 L, E231G R, RBS, close to RBS + + n.a. No [21]
R/K216E, S221P R, HA1–HA1, RBS ++ – +0.3 – [35,77,87,146]
K216E R, HA1–HA1 ++ – +0.4 – [35]
S221P R, RBS ++ – -0.2 – [35]
H7 Q226 L+G186V R, RBS ++ + n.a. – [127]
N123 or T125A close to RBS ++ – n.a. – [93,168]
G186E/V/A R, RBS + + n.a. – [70,93]
K193R R, RBS + + n.a. – [70]
220 loop deletion R, RBS – ++ n.a. Direct contact [70,92,93]
+G186E R, RBS + + n.a. – [93]
+R205G, (G186E) R, RBS + + n.a. – [93]
S227T R, RBS + + n.a. – [70]
H9 226 L R, RBS + + n.a. Direct contact [84]
+G228S R, RBS + ++ n.a. – [82]
+T189A, G1922R R, RBS, F, HA2 + + n.a. Yes [16,121]
*Exact values of the delta pH of fusion were not provided in the literature.
**Residues 221 to 228
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characteristic of the host cell. In the following section, we will discuss
the importance of receptor binding speciﬁcity and HA stability for
viral infection and host adaptation in more detail.
3.1. Receptor binding speciﬁcity
Sialic acid belongs to a diverse family of sugars terminally linked
to different carbohydrates (mostly galactose) either by α-2,3
(SAα-2,3Gal) or α-2,6 (SAα-2,6Gal) glycosidic bond. The kind of link-
age is of great importance since different HA subtypes have different
preferences in binding to one of these SA linkages. Whereas avian inﬂu-
enza HAs preferentially bind to SAα-2,3Gal, human adapted HA sub-
types have been shown to favor SAα-2,6Gal [68–71]. The preference
of avian viruses to bind SAα-2,3Gal matches the occurrence of this
sugar on epithelial cells in the intestinal tract of birds, the replication
site of avian inﬂuenza viruses. In contrast, the human upper respiratory
tract is rich in SAwithα-2,6 linked carbohydrates and thusmight not be
infected by avian inﬂuenza viruses [72]. The human lower respiratory
tract was shown to contain SAα-2,3Gal, favoring avian inﬂuenza virus
infection. Furthermore, avian inﬂuenza viruses target different cells in
the tissue sections of the human lung than human ones [73–75].
Although many studies reported dual receptor binding, meaning the
HA protein of some strains binds both,α-2,3 andα-2,6 linked receptors
[76,77], there is usually a preference for one of these linkages. Receptor
speciﬁcity is thus to be understood as preferential binding being animportant determinant of host speciﬁcity and thus considered as
major interspecies barrier [9,78].
3.1.1. Residues affecting HA receptor speciﬁcity
Successful host adaptation of different HA subtypes has been shown
to require the substitution of certain amino acids in the RBS associated
with a switch in receptor binding speciﬁcity (from SAα-2,3Gal to SAα-
2,6Gal or vice versa). For some subtypes (H1, H2 and H3), amino acid
changes in the RBS resulting in a switch to preferential SAα-2,6Gal bind-
ing have already been identiﬁed (E190D and G225D for H1, G226L and
G228S for H2 and H3). These substitutions did not only confer α-2,6
binding and infection of humans but also successful transmission be-
tween human hosts resulting in the past four human pandemics
(1918: H1N1, 1957: H2N2, 1968: H3N2, 2009: H1N1) [79,80]. In con-
trast, adaptive substitutions required for the circulation of current
avian strains in the human host such as H5N1, H7N9 and H9N2 remain
elusive. Only recently, a ferret-transmissible H5N1 strain withmutation
Q226L (in combination with N224K and N158D) was found to bind to
human-type receptors in the samemode as the HA proteins of previous
pandemics [81]. Furthermore, binding to the human receptor of current
human infecting H7N9 (which already contain leucine at position 226)
was enhanced bymutation G228S (as in humanH2 andH3) [82]. It was
shown that the substitutionof glycinewith serine at position 228 results
in a network of inter-residue interactions between the RBS of H7 and
the human receptor which is comparable to the interaction network
of the H3 RBS with its bound receptor. H5, H7 and H9 subtypes are of
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been shown to infect humans in a number of cases [11,83,84]. Other
mutations that were found to increase SA α-2,6Gal binding or reduce
SA α-2,3Gal are listed in Table 1.
Interestingly, the introduction ofmutations Q226L andG228Swhich
led to successful adaptation of H2 and H3 subtypes to the human host,
also increased the ability of the H5 and the H7 subtypes to bind to
human-type receptors [82,85,86]. In contrast, human adaptive muta-
tions of H1 resulted only in a slight increase of SAα-2,6Gal binding in
the avian H5 subtype but rather in reduced afﬁnity for SAα-2,3Gal
(E190D) or total abolishment of glycan binding (E190D, G225D) [87].
Imai et al. identiﬁed by random mutagenesis and glycan array analysis
that mutations N224K and Q226L in A/Vietnam/1203/2004 (H5N1)
confer binding solely to α-2,6 linked SA. Binding and replication of
this mutant virus was further increased by substitution of N158 [21].
A similar study byHerfst et al. using a combination of targetedmutagen-
esis followed by serial viral passage in ferrets also resulted in an addi-
tional mutation of N158 or of T160 [20] in addition to previously
inserted Q226L and G228S known to enhance SAα-2,6Gal binding in
several HA subtypes. Mutation of asparagine at position 158 or of
threonine at position 160 was reported also in other studies to enhance
preference for human-type receptors due to the loss of the same glyco-
sylation site on the top of the HA1 globular head [88,89]. These ﬁndings
support the previous suggestion that glycosylation of HA inﬂuences
virus infection not only in terms of antigenicity but also at the stage of
receptor binding and replication [25]. Other mutations that have been
detected in the RBS of avian strains include N186K, K193R, Q196R and
S227N either together or in combination with other changes in the
avian H5 subtype [21,90,91]. These substitutions have also been associ-
ated with reduced α-2,3 and increased α-2,6 sialoside binding. Similar
substitutions were found in natural isolates of H7 and H9 subtypes
which contribute to increased SAα-2,6Gal recognition [70,84,92]. The
most prominent substitution in H7 is the 220 loop deletion which
seems to facilitateα-2,6-glycan binding [93], whereas in theH9 subtype
leucine at position 226 (such as in humanH2 andH3)was shown to en-
able replication in the human airway epithelium [84].
3.1.2. Methods to assess receptor speciﬁcity
Rogers et al. in 1983were among the ﬁrst to study receptor speciﬁc-
ity using sialidase treated (asialo) erythrocytes which were speciﬁcally
re-sialylated with either α-2,3- or α-2,6-linked SA [68]. Aside from this
elegant approach that is still used in current studies [80,94], solid-phase
binding assays or glycan arrays represent a convenient way to analyze
HA-receptor interactions [95]. These methods allow the analysis of a
wide number of SA-linked carbohydrates coupled to a ﬂat surface.
This surface can either be probed with intact viruses [21,92] or puriﬁed
HA [96,97]which are subsequently detected usingmonoclonal antibod-
ies. Other methods for the evaluation of receptor binding include NMR
[98,99], surface plasmon resonance (SPR) and single-virus force spec-
troscopy (SVFS) [100–102]. Recently, surface bilayer interferometry
and microscale thermophoresis have been used for quantitative recep-
tor binding studies [81].
In most of these studies, puriﬁed SA receptors were used as binding
partners for HA or virus particles providing very accurate binding pro-
ﬁles and afﬁnities. However, results are hardly comparable due to differ-
ent ligand densities and sample preparation, which most likely affect
receptor binding. For example, it was shown that multivalent nano-
particles showed differential virus binding depending on the surface
density of sialic acid [103]. For methods such as SPR, dissociation is
often underestimated due to the high re-association rates, which can
be ascribed to themultivalent character of binding as it is the case for vi-
ruses [81,102]. Also using SVFS, unbinding rates must be considered
carefully since two dimensional dissociation resulting from immobiliza-
tion of the ligand to a force transducer leads to reduced ligand entropy.
However, SVFS is the only tool that enables virus-cell adhesion mea-
surements in a set-up that closely mimics the natural situation. Usingthis method it could be shown that the resulting cellular binding speci-
ﬁcity of inﬂuenza virusmay not necessarily resemble the receptor spec-
iﬁcity of HA [102]. Hence, the unique presentation of the ligand on the
host cell membrane has an important inﬂuence on virus binding and
should be considered when assessing receptor speciﬁcity of different
HA subtypes and viruses, i.e. host cell speciﬁcity is not only determined
by the presence of SAα-2,6Gal or SAα-2,3Gal but also by the organiza-
tion on the cell surface (see below).
3.1.3. Role of receptor binding speciﬁcity in viral infection
Despite themany indicated studies stating the importanceof speciﬁc
residues for increased SAα-2,6Gal or SAα-2,3Gal preference, variations
in receptor binding do not always correlate with the amino acid compo-
sition [76]. For example, H1 from inﬂuenza A/Cal/09 (H1N1), an isolate
from the recent pandemic (swine ﬂu, 2009), with aspartic acid at posi-
tions 190 as well as 225 should preferentially bind human type recep-
tors. In contrast, the virus exhibits pronounced dual binding to both
receptors, a property that is opposed to seasonal H1 viruses and might
be linked to the pandemic character of A/Cal/09 [76]. H3 from A/X-31,
which originates from the pandemic virus A/Aichi/2/68 (H3N2) also
shows dual binding behavior [76]. Also, in two independent studies of
H5N1 tropism in the respiratory tract of mammals it was found that
the viruses replicated well in both the lower and upper respiratory
tract of ferrets in vivo [104] and in upper respiratory tract epithelia in
humans ex vivo [72] despite the lack of SAα-2,6Gal binding. Hence, it
is difﬁcult to make predictions about receptor binding and infection
based only on the amino acids present in the RBS and on the kind of
SA linkage.
Other critical amino acids have been shown to affect binding [79]
leading to a preference for certain types of carbohydrates linked to SA
[87,93], i.e. many other factors might play a role in receptor speciﬁcity
apart from the structure of the receptor binding site such as the carbo-
hydrate modiﬁcation of SA on the host cell surface. Chandrasekaran
et al. [105] and Stevens et al. [97] postulate that human inﬂuenza
viruses bind to a muchmore structurally diverse set of SA linked carbo-
hydrates than avian viruses which goes beyond the general preference
of α-2,3 or α-2,6 linkage [67]. In another study the glycosylation state
of the virus itself (i.e. of its HA) has been shown to affect virus attach-
ment and uptake depending on the speciﬁc host cell [96]. Being a
transmembrane protein, HA follows the secretory pathway with post-
translational modiﬁcations taking place in the ER and the Golgi [106].
The glycosylation state of HA thus strictly depends on the cell type
and has been shown to alter receptor speciﬁcity [97]. But if viral attach-
ment to the cell surface is inﬂuenced by the host cell in many ways the
question arises of how crucial the initial HA–SA contact is for inﬂuenza
virus infection. Furthermore, it is not yet known if the presence of sialic
acid on the cell surface is strictly required for binding and uptake of the
inﬂuenza virus particle [107].
Indeed, virus binding does not always correlatewith infection per se.
For example, MDCK cells have higher infection efﬁciencies compared to
CHOcells [108] although humanH3N2 (X-31) displays better binding to
CHO than to MDCK cells, suggesting the existence of other post-
attachment factors necessary for efﬁcient infection in MDCK cells. This
ﬁnding is supported by the study of Nunes-Correira et al. [109] who
present a kinetic model for virus binding and endocytosis in MDCK
cells pointing out two kinds of binding sites: (1) low-afﬁnity receptors
responsible for binding and (2) high afﬁnity receptors responsible for
uptake. Also other studies have implicated the dependence of viral up-
take on other post-attachment factors [110,111].
Stray et al. [107] provided evidence for inﬂuenza virus infection in
the absence of sialic acid, suggesting other possible attachment factors
involved in virus binding. Of these, L-SIGN and DC-SIGN, C-type lectins
(LC-SIGN and DC-SIGN), were found to participate in inﬂuenza virus at-
tachment independent of SA speciﬁcity [112]. Furthermore, blocking of
ﬁbronectin was shown to interfere with inﬂuenza A virus entry [113].
Interestingly, only α-2,6 speciﬁc viruses were affected. All of these
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yond the level of HA–SA binding.
The involvement of multiple entry pathways [114], the de novo
induction of clathrin-mediated endocytosis [115] and the use of speciﬁc
adaptor proteins such as Epsin 1 [116] suggest that more speciﬁc signals
than the initial HA–SA contact are necessary to trigger internalization and
promote infection. Indeed, other cellular signaling factors are activated
upon virus infection such as protein kinase C and phosphatidylinositol-
3 kinase (PI3K) as reviewed by Grove and Marsh [117]. Clustering of
sialylated receptor tyrosine kinases such as the epidermal growth factor
(EGF) and the c-Met receptor has been reported to facilitate virus inter-
nalization by inducing tyrosine kinase andPI3K signaling [118]. These sig-
nalsmight be themissing link betweenbinding and infection, not only for
successful endocytosis, but also in context of the innate immunity, which
might also be directly connected to receptor binding. In a recently pre-
sented hypothesis, virus binding to either human or avian type receptors
activates differential immune signaling pathways [119], a factor that is
important considering preferred binding or more dual-binding behavior
of inﬂuenza viruses.
3.1.4. Role of receptor binding speciﬁcity for host adaptation
and transmissibility
Many studies aiming at predicting and preventing the emergence of
a new pandemic evaluated the impact of receptor binding speciﬁcity in
the course of viral adaptation to a different host and its transmissibility
[67,85]. Despite an increased binding toα-2,6 linked SA and efﬁcient in-
fection of human respiratory tract tissues [72,120], most of the above
described substitutions in the avian H5, H7 or H9 strains were not
able to confer respiratory droplet (RD) transmission in the ferret
model (Table 1) [21,86,93,121]. A possible explanation is that most ofFig. 5.HA receptor binding site fromhuman (A) and avian (B, C, D) inﬂuenza viruses complexed
H3N2 (PDB ID: 2YPG) has leucine at position 226 facilitating binding to the human receptor
(A/VN1194, PDB ID: 4BGY3) has a glutamine at position 226, favoring the trans motif of avian
(PDB ID: 4BH3) in the same mode as human H3, most probably due to the Q226L mutation (C
substantially decreased due to leucine at position 226 as illustrated in the image (D).these HA mutants retained their capacity to bind SAα-2,3Gal (dual re-
ceptor binding) and thus can be inhibited by mucins. These sialic acid-
rich substances are secreted from human lung epithelial cells and also
carry α-2,3 linked SA speciﬁcally inhibiting viruses with SAα-2,3Gal
preference [122]. Therefore, it seems that apart from enhanced α-2,6
glycan binding, the virus also pursues a reduction of α-2,3 glycan bind-
ing for successful human-to-human transmission. The recently studied
receptor preference of a ferret-transmissible H5N1 strain also displayed
drastically decreased binding to avian type receptors whereas prefer-
ence to human type receptors was only slightly increased compared to
the non-transmissible wild type, conﬁrming that reduced SAα-2,3Gal
binding might be very important for human infection and successful
transmission [21,81].
Furthermore, mutations in or near the RBS that conferred enhanced
α-2,6-glycan binding were often associated with reduced replication
and virulence [21,86,123] suggesting that there are other mutations
needed that retain viralﬁtness during the course of adaptation to a differ-
ent host. Substitutions in the HA1 domain were often associated with a
shift in the pH of membrane fusion, mostly to higher values [21,35,124]
and thus itwas hypothesized that resulting destabilization has to be com-
pensated by a stabilizing factor. This ideawas supported by recent studies
on the respiratory droplet (RD) transmission of a recombinant highly
pathogenic avian H5 virus in the ferret model. Mutations conferring
SAα-2,6Gal binding were shown to increase the pH of fusion and were
not able to infect co-housed ferrets by this mode of transmission. Only
with an additional stabilizing mutation (T318I) shifting the pH of fusion
from 5.9 to 5.7 these recombinant viruses were transmitted through
the air and were able to infect other ferrets [20,21].
Also, passage of human H3N2 in mice resulted in much higher viru-
lence, which was not only ascribed to increased α-2,3 glycan bindingwith the human (A, C) and/or avian (B, D) cell receptor. HA from human inﬂuenza A/X-31
analog with 2-galactose (2-Gal) in cis conformation (A) whereas HA from avian H5N1
type receptors (B). The ferret-transmissible H5 of A/VN1194 binds the human receptor
). In contrast, binding of ferret-transmissible H5 to the avian receptor (PDB ID: 4BH4) is
Fig. 6. Summary ofmutationsmodulating the pH of fusion of H3, H5 and H7 subtypes. Twomonomers of the HA crystal structure of A/VN1194 (PDB ID: 2IBX) are displayed with the HA1
subunits in green and salmon, and the HA2 subunit in gray, respectively. Mutations of residues leading to a pH shift of fusion are shown in stick presentation in red, orange and yellow
colors. In the graph these residues are colored correspondingly. The x-axis of the graph shows the delta pH of fusion. Wild-type HA was set to zero and mutations shifting the fusion
pH to higher or lower values are listed according to their location in the crystal structure of HA. Remarkably, most of mutations modulating the pH of fusion are located in one of the
three major regions of conformational change (HA1–HA1 interface, HA1–HA2 interface including the B-loop and the 110-helix and the fusion peptide region). *Residues 160 and 196
did not affect the pH of fusion; however, both were shown to increase the ability of the H5 subtype to bind to human type receptors as well as to transmit between ferrets. Due to
their importance for host adaptation these amino acids were highlighted in the HA structure.
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at position 218 of HA1 and 156 of HA2 (Table 1). Again, G218Wnear the
RBS resulted in signiﬁcant destabilization of HA [124,125] whereas
T15621 did not show a large effect on the pH of fusion. However,
T1562 also participates at a potential glycosylation site (position
N1542) [124]. These studies indicate that aside from receptor binding
speciﬁcity also other cell-speciﬁc factors contribute to better suscepti-
bility and higher virulence in a different host. Still, over the course of
host adaptation of different virus strains, amino acid substitutionsmost-
ly occur in or near the RBS, strongly indicating that a “suitable” receptor
binding pocket plays a pre-dominant role for host-speciﬁc virus infec-
tion [82,85]. Recent comparison of the above described “transmissible”
H5 subtype with its avian counterpart in complex with avian and
human receptors conﬁrms that the substitutions in the RBS (Q226L,
N224K) result in an altered sialic acid binding orientation which is
more similar to the binding mode of H2 and H3 pandemic viruses
[81]. In these subtypes the G226L mutation causes widening of the
space between the 130 loop and the 220 loop of the RBS subtypes.
This structural change was also previously described as a requirement
to bind the α-2,6 cis linkage of human type receptors instead of the
avian α-2,3 trans motif [127] (Fig. 5). Interestingly, a Q226L mutation
was shown in many avian viruses to confer SAα-2,6Gal binding and
even human infection (Table 1), not only for H5N1 viruses, but also in
natural occurring H9N2 [84] and the recent H7N9 strains [127]. For
the H5 subtype, leucine at position 226 has not been found in any natu-
ral isolate and usually additional substitutions were required for en-
hanced SAα-2,6Gal binding. These amino acids (G228S, Q196R,
N224K) were associated with the binding of other components of the
cell or facilitate binding due to the loss of a glycosylation site (T160A,1 Index 2 indicates that the residue is located at position 156 of the HA2 domain. HA1
residues do not carry an index. All subsequent residues are labeled accordingly. H3 num-
bering is used throughout.N158D) [20,21,86,88,91]. Recently, the network of inter-residue inter-
actions of H3 and H7 RBS in complex with the human type receptor
was analyzed [82]. Residues which interact with the adjacent sugars of
sialic acid were shown to include also the 140 and 150 loops of the re-
ceptor binding domain possibly inﬂuencing the afﬁnity to a certain
receptor.
In any case, viral adaptation mostly required several passages to ob-
tain acceptable viral titers for a respective host [20,108] suggesting a
multifactorial trait of receptor binding and infection that has to be opti-
mized in a long process of selection.
3.2. HA stability
Temperature and acid stability of HA has been shown to differ
among HA subtypes [128–130] as well as between viruses of the same
subtype [35,131]. The stability of HA is usually measured over a range
of different pH values or temperatures. The conformational change is ir-
reversible, which provides inactivation as amarker for stability. In prac-
tice, after a pre-incubation step at the respective pH or temperature, the
activity of HA is tested, e.g. membrane fusion, to determine the thresh-
old of inactivation [21,132]. The divergence in the inactivation kinetics
and thus stability of the HA is ascribed to structural variations in the
protein ectodomain that have been identiﬁed by comparison of the var-
ious crystal structures [35,133–136]. However, the biological signiﬁ-
cance of HA stability has not yet been fully clariﬁed but it seems to be
another hallmark of HA affecting the infection potential of the whole
virus.
3.2.1. Residues affecting HA stability
The conformational change of HA, and thus membrane fusion and
virus infection, does not depend only on the efﬁciency of cleavage but
also on the stability of the protein itself. The meta-stable HA1–HA2
structure resulting from HA0 cleavage is thought to be stabilized by
the HA1 domain acting like a “clamp” on HA2 thereby preventing its
Table 2
Residues modulating the pH of membrane fusion of different HA subtypes.
Avian
HA
Residue (H3
numbering)
Position Delta fusion pH
[units]
Literature
H1 L78P, Q354H E', F HA1 − 0.2 (↕) [123]
H3 H17A/E/R F', HA1 +0.4 [125,137,139]
H17Y F', HA1 −0.3 [125,137]
D132N F', HA1 +0.2 [169]
T212E,N216R R, HA1–
HA1
No fusion [138]
T212C,N216C R, HA1–
HA1
No fusion [147,148,170]
P162S R, HA1 +0.2 [124]
Q210R R, close to
RBS
+0.15 [124]
G218E/W
(+T2156N)
R, HA1–
HA1
+0.4 [108,124,139]
I62M F, HA2 +0.3 [125]
F92L F, HA2 +0.6 [125]
Q472R F, HA2 +0.35 [125]
K512A/E F, HA2 −0.3 [137]
R542K F, HA1–
HA2
+0.25 [125]
K582I F, HA1–
HA2
−0.6–0.8 [139,170]
F632P, F702P F, HA1–
HA2
No fusion [63]
E812G F, HA2 +0.3 [125]
Q1052K F, HA2 +0.3 [125]
H1062A/R F, HA2 −0.4 [61,137]
T1112H/V/A F, HA2 +0.6,+0.3,+0.1 [137]
D1122A/G F, HA2 +0.4, +0.5 [125,137]
N1142K F, HA2 +0.6 [125]
T1562N F, HA1–
HA2
−0.1 [124]
H5 Y17H F' , HA1 +0.4 [144,154,155]
H18Q F' , HA1 −0.3 [144,154,155,171]
D104N, T115I E', HA1–
HA2
−0.25 [35,146]
K216E R, HA1–
HA1
+0.4 [35]
S221P R, RBS −0.2 [35]
Q226 L, G228S,
N158D
R, RBS +0.3 [21]
+T318I F', HA1 −0.3 [21]
Q226 L, G228S,
T160A
R, RBS +* [20]
+H110Y E', HA1–
HA2
−* [20,101]
K512D F, HA1–
HA2
−0.1 [144]
K582I F, HA1–
HA2
−0.3–0.4 [144,153,155]
H1112A F, HA2 No fusion [144]
N1142K F, HA2 +0.5 [155]
H7 R32G F’, HA1 +0.2 [125]
R91Q/L R, HA1 +0.1, +0.3 [125]
R300S F’, HA1 +0.3 [125]
F32L F, HA2 +0.4 [125]
G232C F, HA2 +0.1 [172]
Q472L F, HA2 +0.45 [125]
K512D F, HA1–
HA2
−0.1 [144]
R542K/G/S F, HA1–
HA2
+0.1,+0.3 [125]
K582I/N F, HA2 −0.7 [170]
I812S F, HA1–
HA2
+0.1 [125]
D1122G F, HA2 +0.4 [125]
E1142K F, HA2 +0.5 [125]
*Exact values for the delta pH of fusion were not provided in the literature.
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subunits andmonomers contribute to the stabilization of this structure.
During endosomal acidiﬁcation, key residues located in these critical in-
terface regions are protonatedweakening the interactions and thus trig-
gering the structural rearrangements leading to membrane fusion
[125,137–139]. It is well known that the stability, ﬂexibility and func-
tion of HA largely depends on electrostatic interactions at interfaces
such ashydrogen bonds and salt bridges, and vanderWaals interactions
[140–142]. These interactions are important for keeping the meta-
stable conformation at neutral pH. Thus, substitution of a number of res-
idues has been shown to modulate HA stability what in turn affects the
pH of membrane fusion. For an overview, see Table 2. Analysis of a
variety of so called “fusion mutants” has revealed the importance of
some key residues and their interactions at several domain and subunit
interfaces which are partially conserved throughout HA subtypes
[56,125,138] (Fig. 6).
3.2.1.1. Residues in the fusion peptide pocket. As mentioned earlier, the
most stabilizing part of the protein is the coiled-coil structure of the
HA2 stalk domain with its transmembrane region [38] being mostly
retained during conformational change; only a small part of the long
α-helix (helix A) undergoes a structural transition (Fig. 4). One of the
most determinant regions for the HA conformational change includes
the fusion peptide and the pocket where it is intercalated. The ﬁrst ten
N-terminal residues of the fusion peptide and some residues in the fu-
sion peptide pocket are highly conserved. For example, the aspartic
acids at positions 109 and 112 in the pocket form strong hydrogen
bonds with fusion peptide residues 2, 3, 4 and 5 [136] (Fig. S1). Accord-
ingly, amino acid deletions or substitutions in the peptide or the cavity
surrounding it, disturb these balanced interactions signiﬁcantly affect-
ing the fusion activity of HA [56,123,125,143–145]. However, not all of
the residues lining the fusion peptide pocket are conserved resulting
in local structural differences among subtypes. Based on these differ-
ences, the known 17 HA subtypes (except bat-derived H17) have been
classiﬁed into ﬁve structural clades which were again divided in two
groups according to the characteristics of the fusion peptide region:
Whereas residues K512 (HA2 stalk domain), D1092, and D1122 of the
pocket are completely conserved throughout all subtypes, residues
H17 (F′ fusion subdomain), H1062 and H1112 of HA2 (F fusion
subdomain) are group speciﬁc [137]. The H3 group (H3 and H7
subtypes) carries His at positions 17 and 106 and a neutral amino acid
(alanine or threonine) at position 111, whereas the H1 group (e.g. H1,
H2, H5 subtypes) has a Tyr at position 17, an arginine or lysine at posi-
tion 106 and a histidine at position 111. Substitution of these amino
acids (H17 in H3, Y17 in H5, H2106 in H2 and H3 [61,137] and H1112
in H5 [144]), affected the fusion pH in H3 and H5 subtypes signiﬁcantly
suggesting that important interactions in the HA protein are preserved
rather than the amino acid sequence. For example, it was hypothesized
that at low pH the protonated H1062 forms repulsive interactions
with K512 of the stalk what might be important for bending of helix A
after the formation of the extended intermediate (as described in
Section 2.3). These are lost when mutating one of these residues to a
neutral amino acid, thus leading to a decrease of the fusion pH [137]. In-
terestingly, mutating the H1062 to R1062 (which is naturally present in
all H1 group HAs) led to a signiﬁcant stabilization of HA although it is
positively charged, even at neutral pH [61]. These results emphasize
that it is very difﬁcult to predict important interactions or the exact
role of conserved residues for the HA conformational change even
with structural information.
3.2.1.2. Residues at the HA1–HA2 interface.With the release of the fusion
peptide, the inter-helical loop B of HA2 undergoes a loop-to-helix tran-
sition upon protonation at low pH. As described earlier, this process re-
quires reorganization of interactions at the HA1–HA2 interface. Thus,
involved residues certainly play a role in the regulation of conforma-
tional change. The interface is formed between loop B (HA2) and theR, E′ and F′ subdomains of the HA1 subunit [134]with involved residues
85–90, 104–115 and 265–270 of HA1 and 64–72 of the HA2. Some of
these residues are conserved and thus also the interactions among
them such as the tetrad salt bridge between E89, R109, R269 of HA1
and E672 of HA2 [138]. Rachakonda et al. [138] demonstrated the
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fusion activity of HA. The deletion of conserved and the introduction
of new salt bridges resulted in a pH shift of membrane fusion. Also
other authors reported substitutions at the HA1–HA2 interface (posi-
tions 17, 18, 104, 110, 115 and 318 of HA1 and 47, 51, 54, 58, 59, 63
and 70) that signiﬁcantly affect the pH of fusion [20,35,101] (Table 2,
Fig. 6).
3.2.1.3. Residues at the HA1–HA1 interface. Only a few studies have re-
ported mutations at the HA1–HA1 interface which could potentially in-
ﬂuence fusion activity of the HA protein [138,139,146,147]. Thus, there
is only little evidence about stabilizing interactions between the globu-
lar top domains of HA1 (Fig. S2). By the introduction of disulﬁde bonds
[147,148] or salt bridges [138], it was shown that the dissociation of the
HA1 monomers is required to allow the whole conformational change
of HA. Refolding of HA2 also occurs spontaneously at neutral pH
[33,55,59]. It was thus proposed by Huang et al. that protonation of
HA1 might be sufﬁcient for HA conformational change and membrane
fusion [59]. However, there is no experimental evidence to support
this and residues being protonated at low pH are largely unknown.
Interestingly, some studies have reported that mutations in or near
the RBS may affect the fusion pH of several subtypes suggesting that
the HA1 domain is very sensitive to structural variations [21,35,124].
Antigenic drift resulting in the substitution of amino acids in the recep-
tor and antigenic binding sites are often associatedwith themodulation
of inter-monomeric contacts of HA1 andmight thus be a strategy of the
virus to control several functions at the same time.
To summarize, electrostatic interactions throughout the HA mole-
cule contribute to the stabilization of different HA subtypes and thus
play an important role for HA conformational change. The number of
HAmolecules undergoing a conformational change determines the efﬁ-
ciency of fusion with the endosomal membrane what in turn might af-
fect the infectivity of an inﬂuenza virus strain [149,150]. Some of the
ionizable residues and their interactions (e.g. H17, R220, R229 of HA1,
D1092 and D1122 of HA2) are buried in the cleaved HAwithout contact
to neighboring ions giving them the potential to destabilize the struc-
ture upon their protonation [43]. Daniels et al. [125] reported that HA
mutants isolated from amantadine resistant strains (X-31 (H3N2) and
Weybridge virus (H7N1)) could be divided into two groups depending
on the location of amino acidmodiﬁcation: One group had substitutions
in proximity to the fusion peptide resulting in the destabilization of in-
teractions between the peptide and residues of the pocket. The other
group contained mostly substitutions at inter-subunit contacts leading
to structural changes at the HA1–HA2 interface. Also adaptation of
egg-grown X-31 (H3N2) to mammalian cells resulted in mutations in
these two regions resulting in a shift of the fusion pH [139]. This con-
ﬁrms the central role of these parts for the stability of HA. However, it
is still not clear which are the key residues that get protonated upon
acidiﬁcation.
Stevens et al. [87,135] described pH-sensitive histidine patches that
might play a role in triggering the dissociation of subunit and domain in-
teractions in the two regions described above. Histidine residues are
generally known to act as “pH sensors” in class I and class II fusion pro-
teins due to their pKa~6 (=pHof protonation). Hence, their protonation
matches the pH region of membrane fusion in the endosome [151–152].
It was further suggested that sequential protonation of histidines at po-
sitions 18 and 38 in HA1 and at positions 106/111 and 142 controls the
structural transitions of HA [57,87,151]. The exchange of histidines and
of neighboring (mostly charged) residues had a signiﬁcant effect on
the fusion pH (Table 1) proposing that the pKa of histidine can be mod-
ulated by the surrounding residues thereby affecting the pH of the con-
formational change, and in consequence, of membrane fusion [137]. It
was also proposed previously that the substitution of charged residues
might play a dominant role in the course of virus adaptation [125].
In any case, the described studies highlight the importance of ener-
getically favored interactions between domains and subunits thatpreserve the HA protein in its native, meta-stable structure. Subtype-
speciﬁc differences in sequence and structure reﬂect the versatility of
the virus to form these interactions throughout the HA molecule
[133–134]. Thereby the precise balance of charged residues might play
a key role in the evolution of inﬂuenza viruses regulating the electro-
static interactions within the trimer what in turn affects fusion activity
in the endosome.
3.2.2. Role of HA stability for virus infection and host adaptation
The pathogenicity of avian H5N1 inﬂuenza virus strains in chickens
has been recently linked to the acid stability of their HA proteins
[35,146]. AHPAIV strain had an elevatedpHof fusion (pH5.7) compared
to a moderately pathogenic virus (pH5.5) due to mutations N104D and
T115I which destabilize the 110-helix and its interaction with the
neighboring HA2 subunit (Fig. 6). However, for infection of mammals
a lower pH of fusion and thus enhanced temperature and acid stability
seems to be essential in order to achieve optimal uptake bynasal epithe-
lial cells [153]. It was thus suggested that adaptation to a different host
does not only require binding to the cell-surface speciﬁc receptors but
also needs to acquire an optimal pH of membrane fusion [35,154,155].
Indeed, it could be shown that HA mutant viruses with a higher pH of
fusion (pH 5.5–6.0) replicated with better efﬁciency in ducks than in
mice. In contrast, replication of HA mutant viruses characterized by a
lower pH of fusion (pH 5.0–5.5) was supported only in mice, but not
in ducks. These studies provide evidence for a different requirement of
acid stability for avian and mammalian inﬂuenza viruses depending
on their activation pHs [154,155].
Differences in acid stability of avian and human inﬂuenza viruses
which have also been reported in other studies [21,130] might have a
simple explanation. The endosomal pH determines the time point of fu-
sion and can vary among different cell lines [156]. This has two conse-
quences for the virus: (1) The earlier the viral genome is released
from the endosome, the earlier the cellular immune response is stimu-
lated upon recognition of the viral RNA [24]. Therefore, from the viral
perspective, membrane fusion in close proximity to the nucleus is fa-
vored, so that the time frame between vRNP release and transport
into the nucleus is minimized. (2) At the same time, fusion has to
occur before the endosome has matured into a lysosome where the
virus particle would be otherwise degraded [157]. This explanation is
supported by several studieswhere adaptation to a different host result-
ed in a pH shift of membrane fusion, nomatter if it was adaptation from
egg-grown viruses to mammalian cells [139], during passage of a
human derived strain (H3N2) in mice [108,124], or as a result of adap-
tation from MDCK grown viruses to Vero cells [156].
3.2.3. Role of HA stability for RD transmission
Another explanation for differential requirements of acid stability
can be deduced from the mode of viral transmission which also differs
between birds and mammals. Wild birds are the natural reservoir for
avian inﬂuenza viruses and spreadingwithin these aquatic bird popula-
tions occurs through an indirect fecal-oral route involving contaminated
water on shared aquatic habitats. It was found that the chemical and
physical conditions of thewater (pH, salinity, and temperature) can sig-
niﬁcantly inﬂuence the stability of avian inﬂuenza viruses [155,158].
Thus, in wild birds a higher acid stability might be favored for efﬁcient
spreading of the virus [131]. HPAIV which are associated with rather
low stability compared to LPAIV, are known to have developed by adap-
tation fromwild birds to poultry by formation of the polybasic cleavage
site [15]. Transmission in poultry might not require high acid stability
probably allowing evolution of this highly pathogenic phenotype. How-
ever, it remains to be determined if cleavage activation and an elevated
pH of fusion evolved in parallel or in an independent manner.
In contrast, for spreading via respiratory droplets, which is generally
accepted as the primary transmission mode in humans [159], the virus
has to pass the human nasal airway epithelium which is known to be
mildly acidic. Thus, in addition to theprerequisite of SAα-2,6Gal binding
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mational change of HA, and thus inactivation of the virus, before cell
entry. Indeed, infection efﬁciency of an avian inﬂuenza H5N1 virus in
mice was shown to be enhanced by a stabilizing mutation in the HA2
domain (K582I) [153,154]. This residue is also located at the HA1–HA2
interface where the exchange of a charged residue could lead to a de-
crease of the fusion pH [137,144]. It was reported that the mutated
strain retained infectivity at pH 5.6 whereas infection of the wild type
strain was limited to pH5.8 resulting in reduced infectivity in the intra-
nasal infection ofmice,most likely due to the lowpHof themucosal sur-
face [153]. This ﬁnding was supported by two recent studies of Zaraket
et al. reporting an increased viral growth of the K582I mutant in mice as
well as in the upper respiratory tract of ferrets due to the lower fusion
pH [154,160] whereas in infected mallards no physiological symptoms
could be detected [155]. The glands of the nasal epithelia in mice are
quite similar to those in humans, however the transmissionmode is dif-
ferent. Inﬂuenza virus infection of ferrets along with their symptoms is
muchmore comparable to the infection in humans. Hence, ferrets are a
widely usedmodel system to study transmissibility. As described above,
also in this model it could be shown that, apart from SAα-2,6Gal recep-
tor preference, a stabilizingmutation in theHAproteinwas required for
efﬁcient RD transmission between ferrets [20,21]. Crystal structure
analysis of the transmissibility conferring mutation reported by Imai
et al. revealed that residue 318 is situated in proximity of the fusion
peptide where substitution of threonine to isoleucine contributes to
the stabilization of this structure [81]. Herfst et al. reported mutation
H110Y to be responsible for better transmissibility between ferrets.
The exchange of histidine at position 110 to a tyrosine was shown to
stabilize the intra-trimeric contact (HA1–HA2 interface) due to an addi-
tional hydrogen bond to the adjacent monomer [20,101].
Accordingly, it could be shown that a stabilizing mutation alone is
not sufﬁcient for an avian H5N1 virus to transmit between ferrets, not
even via direct contact [160]. Thus, together with increased HA stability,
increased SA-2,6Gal binding is indispensable for the transmissibility of
an avian inﬂuenza virus between mammals [20,21,91,161].
However, studies on the airborne-transmissibility in ferrets were
mostly performed with recombinant viruses which contained viral
genes of human adapted strains [16,21,91,161] most likely contributing
to successful replication and transmission. Thus, the experimental con-
ditions used for assessing ferret transmissibilitymight not represent the
conditions for transmissibility of a natural virus strain. Furthermore, it
is difﬁcult to make assumptions for inﬂuenza virus transmission in
humans based on the results obtained with ferret studies. Still, for
human infection and/or human-to human transmission higher acid
stability of the viral HA seems to bemandatory. Galloway et al. [130] re-
cently compared cleavage activation and fusion pH of several human
and avian inﬂuenza virus strains. The last human pandemics were
caused by strains of lower pathogenicity and rather high stability.Table 3
Summary of human- and ferret-transmissible inﬂuenza virus strains to date.
Avian HA Residues in the RBS Receptor speciﬁcity Delta fusion pH RD tr
α-2,3 SA α-2,6 SA
H1 E190D, G225D – ++ n.a. Yes
H2, H3 Q226 L, G228S – ++ n.a. Yes
H5 Q226 L, G228S, Q196R – ++ n.a. No
Q226 L, G228S, Q196R – ++ n.a. No
Q226 L, G228S, Q196R – ++ n.a. Yes
Q226 L, G228S, T160A – ++ + No
+H110Y – ++ – Yes
N224K, G226 L, N158D/A – ++ +0.3 No
[21,88,89]
+T318I – ++ −0.3 Yes
H7 Q226 L+G186V n.a. n.a. n.a. No
220 loop deletion – ++ n.a. No
H9 226 L + + n.a. No
+T189A, G1922R + + n.a. YesThus, most HAs derived from human isolates mediated membrane fu-
sion at 0.1–0.5 pH units lower than those of the same subtype derived
from an avian species (except from H5) conﬁrming the pre-condition
of HA stability for viral spread in the human population. Thus, the pH
of triggering the conformational change of the inﬂuenza virus hemag-
glutinin is certainly an important factor to consider in the evaluation
of newly emerging strains [130].
4. Conclusions
Inﬂuenza A virus cell entry is mainly determined by the HA protein
whichmediates both viral attachment andmembrane fusion, eventually
leading to the release of the viral genome into the cell cytoplasm.
Both functions have been studied extensively and were also the
focus of this review. Some structural features involved in receptor bind-
ing and conformational change are conserved throughout evolution and
thus small differences in the amino acid composition may signiﬁcantly
affect these functions leading to the diversiﬁcation of subtypes and
clades with different binding and fusion behavior.
In this review, we described the inﬂuence of structural variations on
the receptor binding speciﬁcity and stability of HA and their role in host
infection and adaptation. We conclude that infection of a certain host
seems to require a more cell-speciﬁc adaptation of the HA protein
which might not necessarily be related to HA receptor binding. In con-
trast, for sustained inter-species transmission of inﬂuenza viruses, bind-
ing to the host-speciﬁc SA receptors as well as adaptation of HA stability
seem to be required. All strains from the last human pandemics (H1N1
2009, H2N2 1957 and H3N2 1968) as well as more recent ones (H5N1,
H9N2, H7N2, H7N9), have acquired substitutions in the RBS that could
be related to a switch or at least an increase in human type receptor bind-
ing [79,82,84,85,93]. Furthermore, most of the ferret- and also human-
transmissible strains contain HA proteins with higher stability [21,130]
than their avian counterpartswhich seems to contribute to the transmis-
sibility of the virus. Therefore, increasedhuman type receptor binding to-
gether with an increase of the HA stability is required for the adaptation
of an avian inﬂuenza virus to the human host [20,85,160].
However, the inefﬁciency of avian-human and human-to-human
transmission for the currentH5N1 andH7N9 cannot be explained solely
by the inability of these viruses to bind and replicate at these sites. Viral
attachment, endocytosis and efﬁciency of membrane fusion were
shown to be inﬂuenced also bymany cell-speciﬁc factors such as plasma
membrane composition, existence ofmultiple entry and signaling path-
ways, presence of host proteases, cellular immunity and likely many
other factors not mentioned here. These additional host cell factors
were not subject of the present study and are described elsewhere
[119,162].
Another question remains that has not been addressed yet. HA sta-
bility and pathogenicity have only been shown to inversely correlateansmission Other viral genes Literature
All genes of human H1N1 [80,163,164]
All genes of human H3N2/H2N2 [68,79,165]
HA and NA of avian H5N1, other of H3N2 [91]
NA of human H1N1, other genes of avian H5N1 [91]
mutant NA of human H3N2, other genes of avian H5N1 [91]
All genes of avian H5N1 [20,89]
All genes of avian H5N1 [20]
HA and NA of avian H5N1,
HA and NA of avian H5N1, other genes of human H1N1 [21]
All genes of avian H7N9 [127]
All genes of avian H7N2 [70,92,93]
All genes of avian H9N2 [84]
NA of avian H9N2, other genes of human H3N3 [16,121]
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quires high stability of the virus, highly pathogenic avian strains associ-
ated with low stability of HAmust not necessarily be highly pathogenic
in humans aswell. In contrast, HPAIVwith a high pH of fusionmight not
replicate verywell in the humanhost. Furthermore, it should not be for-
gotten that also changes in other viral proteins apart from HA are re-
quired for replication in human populations. Human pandemic strains
have been in most cases reassortants from viruses of different origins
[9], whichmight have additional adaptations in other genes. In contrast,
circulating highly pathogenic avian H5N1 strains in 2004 and 2005 as
well as current human infecting H7N9 strains contain all viral genes
of avian origin [83,127] whichmight hinder successful transmission be-
tween humans (Table 3).
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